Lombard Medical

Lombard Medical, Inc. is an Irvine, CA-based medical device company focused on the $1.6bn market for minimally invasive treatment of abdominal aortic aneurysms (AAAs). The Company has global regulatory approval for Aorfix™, an endovascular stent graft which has been specifically designed to treat patients with the broadest range of AAA anatomies, including aortic neck angulation up to 90 degrees. The Company has also achieved CE Mark for the Altura™ endograft system, an innovative ultra-low profile endovascular stent graft that offers a simple and predictable solution for the treatment of more standard AAA anatomies. Altura will be launched in Europe in January 2016, with an international rollout planned for later in 2016.
Company Growth (employees)
Oxfordshire, GB
Size (employees)
111 (est)
Lombard Medical is headquartered in Oxfordshire, GB

Lombard Medical Office Locations

Lombard Medical has office in Oxfordshire
Oxfordshire, GB

Lombard Medical Metrics

Lombard Medical Summary

Market capitalization

$14.1 m

Closing share price

Lombard Medical's current market capitalization is $14.1 m.

Lombard Medical Financials

Lombard Medical's revenue is £2.3 m in FY, 2013 which is a 20% decrease from the previous period.
FY, 2013FY, 2014


£2.3 m£2.9 m

Revenue growth, %


Lombard Medical Market Value History

Lombard Medical Company Life

You may also be interested in